GMA News
AstraZeneca vaccine in Philippines separate from challenged batch –FDA
The Philippines will continue its AstraZeneca COVID-19 vaccination program as the doses that arrived in the country are from a different batch than those being investigated for blood clot concerns in Europe.
Philippine health officials, including the FDA director-general Eric Domingo, confirmed that the specific batch of AstraZeneca vaccines used in the Philippines is not part of the batch being probed.
Both the Department of Health (DOH) and the Food and Drug Administration (FDA) cited that European countries like Denmark and Norway halted their rollouts as precautionary measures during their investigations.
The FDA and DOH affirmed that the benefits of the AstraZeneca vaccine continue to outweigh its risks, a sentiment echoed by the World Health Organization.
Despite Austria suspending a batch due to a death and an illness, the European Medicine Authority (EMA) has stated there is no indication the vaccine was responsible.
The Philippines has received 525,600 doses of the AstraZeneca vaccine through the COVAX Facility.
The DOH and FDA assured the public that they are closely monitoring all vaccines deployed in the country.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines received 38,400 doses of AstraZeneca vaccines on Sunday night, March 7, bringing the total doses from the COVAX facility to 525,600.
+1
Read more →
Presidential Adviser for Entrepreneurship Joey Concepcion stated that the business sector remains confident in the Oxford-AstraZeneca vaccine.
Read more →
AstraZeneca has reaffirmed the safety of its COVID-19 vaccine, stating there is no evidence of an increased risk of blood clots among those vaccinated.
Read more →
The Philippine FDA has granted an emergency use authorization (EUA) for Russia's Sputnik V vaccine, making it the fourth vaccine to receive regulatory approval in the country.
Read more →
The Department of Health (DOH) assures that the 525,600 doses of AstraZeneca vaccines, which expire in May, will be administered before their expiration date.
Read more →